DK166681B1 - Dna-sekvenser, dna-sekvenser og dna-oligonucleotider til brug ved fremstilling af de foerstnaevnte dna-sekvenser, hybridplasmider indeholdende dna-sekvens, vaertsceller indeholdende hybridplasmiderne samt genteknologisk fremgangsmaade til fremstilling af il-2 - Google Patents

Dna-sekvenser, dna-sekvenser og dna-oligonucleotider til brug ved fremstilling af de foerstnaevnte dna-sekvenser, hybridplasmider indeholdende dna-sekvens, vaertsceller indeholdende hybridplasmiderne samt genteknologisk fremgangsmaade til fremstilling af il-2 Download PDF

Info

Publication number
DK166681B1
DK166681B1 DK237985A DK237985A DK166681B1 DK 166681 B1 DK166681 B1 DK 166681B1 DK 237985 A DK237985 A DK 237985A DK 237985 A DK237985 A DK 237985A DK 166681 B1 DK166681 B1 DK 166681B1
Authority
DK
Denmark
Prior art keywords
dna
dna sequence
sequences
ctg
sequence
Prior art date
Application number
DK237985A
Other languages
Danish (da)
English (en)
Other versions
DK237985A (da
DK237985D0 (da
Inventor
Joachim Engels
Eugen Uhlmann
Friedrich Wegenmayer
Hubert Muellner
Ernst-Ludwig Winnacker
Ronald Mertz
Hiroshi Okazaki
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK237985D0 publication Critical patent/DK237985D0/da
Publication of DK237985A publication Critical patent/DK237985A/da
Application granted granted Critical
Publication of DK166681B1 publication Critical patent/DK166681B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK237985A 1984-05-29 1985-05-28 Dna-sekvenser, dna-sekvenser og dna-oligonucleotider til brug ved fremstilling af de foerstnaevnte dna-sekvenser, hybridplasmider indeholdende dna-sekvens, vaertsceller indeholdende hybridplasmiderne samt genteknologisk fremgangsmaade til fremstilling af il-2 DK166681B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3419995 1984-05-29
DE19843419995 DE3419995A1 (de) 1984-05-29 1984-05-29 Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens

Publications (3)

Publication Number Publication Date
DK237985D0 DK237985D0 (da) 1985-05-28
DK237985A DK237985A (da) 1985-11-30
DK166681B1 true DK166681B1 (da) 1993-06-28

Family

ID=6237111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK237985A DK166681B1 (da) 1984-05-29 1985-05-28 Dna-sekvenser, dna-sekvenser og dna-oligonucleotider til brug ved fremstilling af de foerstnaevnte dna-sekvenser, hybridplasmider indeholdende dna-sekvens, vaertsceller indeholdende hybridplasmiderne samt genteknologisk fremgangsmaade til fremstilling af il-2

Country Status (11)

Country Link
EP (1) EP0163249B1 (xx)
JP (1) JPS6199A (xx)
AT (1) ATE65797T1 (xx)
AU (1) AU589896B2 (xx)
DE (2) DE3419995A1 (xx)
DK (1) DK166681B1 (xx)
ES (1) ES8605813A1 (xx)
GR (1) GR851291B (xx)
IE (1) IE57996B1 (xx)
PT (1) PT80542B (xx)
ZA (1) ZA854031B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA849910B (en) * 1983-12-23 1985-09-25 Hoffmann La Roche Purification of recombinant interleukin-2
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
DE3537461A1 (de) * 1985-10-22 1987-04-23 Hoechst Ag Derivat des interleukin-2, seine herstellung und verwendung
US5496924A (en) * 1985-11-27 1996-03-05 Hoechst Aktiengesellschaft Fusion protein comprising an interleukin-2 fragment ballast portion
DE3712985A1 (de) * 1987-04-16 1988-11-03 Hoechst Ag Bifunktionelle proteine
JPS62185098A (ja) * 1986-02-10 1987-08-13 Otsuka Pharmaceut Co Ltd インタ−ロイキン−２活性を有するポリペプチド
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
FR2643646B1 (fr) * 1989-02-27 1993-09-17 Pasteur Institut Expression de sequences de nucleotides codant pour des vesicules a gaz
US6008319A (en) 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
US6955807B1 (en) 1998-05-15 2005-10-18 Bayer Pharmaceuticals Corporation IL-2 selective agonists and antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483592A1 (fr) * 1980-06-02 1981-12-04 Stein Industrie Dispositif de reduction des contraintes thermiques sur un echangeur de chaleur
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
ATE48641T1 (de) * 1984-05-08 1989-12-15 Genetics Inst Ein menschlicher t-zellwachstumsfaktor.

Also Published As

Publication number Publication date
PT80542A (de) 1985-06-01
ZA854031B (en) 1986-01-29
ES8605813A1 (es) 1986-01-16
IE851319L (en) 1985-11-29
AU589896B2 (en) 1989-10-26
EP0163249A3 (en) 1988-05-11
EP0163249B1 (de) 1991-07-31
DK237985A (da) 1985-11-30
DE3419995A1 (de) 1985-12-05
DE3583634D1 (de) 1991-09-05
ES543508A0 (es) 1986-01-16
AU4307085A (en) 1985-12-05
GR851291B (xx) 1985-11-25
ATE65797T1 (de) 1991-08-15
EP0163249A2 (de) 1985-12-04
IE57996B1 (en) 1993-06-02
DK237985D0 (da) 1985-05-28
PT80542B (pt) 1987-09-30
JPS6199A (ja) 1986-01-06

Similar Documents

Publication Publication Date Title
FI91883B (fi) Menetelmä hirudiinin vaikutusta omaavan polypeptidin valmistamiseksi
DK166681B1 (da) Dna-sekvenser, dna-sekvenser og dna-oligonucleotider til brug ved fremstilling af de foerstnaevnte dna-sekvenser, hybridplasmider indeholdende dna-sekvens, vaertsceller indeholdende hybridplasmiderne samt genteknologisk fremgangsmaade til fremstilling af il-2
EP0046039B1 (en) Synthetic urogastrone gene, corresponding plasmid recombinants, transformed cells, production thereof and urogastrone expression
KR920009505B1 (ko) 인체 γ－인터페론 활성을 갖는 폴리펩타이드의 제조방법
KR950000299B1 (ko) 융합 단백질의 제조방법
IE62511B1 (en) Mini-proinsulin, its preparation and use
DK171940B1 (da) Fremgangsmåde til fremstilling af polypeptider meden C-terminal carboxamidgruppe, polypeptider til anvendelse ved fremgangsmåden, fusionsproteiner deraf og dertil egnede DNA-sekvenser, plasmider og værtsorganismer
JPS63304987A (ja) アンギオゲニン類の遺伝子工学産生方法
AU634926B2 (en) Gene synthesis
US4711847A (en) Preparation of secretin
AU592062B2 (en) Synthetic regulation region
DK175511B1 (da) DNA-sekvens, fremgangsmåde til transportekspression af proteiner ved anvendelse af DNA-sekvensen, hybridvektor og hybridplasmid indeholdende DNA-sekvensen samt værtsorganisme indeholdende hybridvektoren eller hybridplasmidet
EP0121569B1 (en) Novel vector
NO851065L (no) Genteknologisk fremgangsmaate til fremstilling av human-gammainterferon og middel til gjennomfoering av denne fremgangsmaaten
GB2223496A (en) Gene encoding human acidic fibroblast growth factor
EP0295286A1 (en) METHOD FOR PRODUCING A SALMON GROWTH HORMONE BY MEANS OF AN ARTIFICIAL GENE.
HU196458B (en) Process for enhancing protein expression by means of the modification of the dna sequence of the trp-operone between the shine-dalgarno sequence and the start codone
GB2210618A (en) Synthetic gene
JPH0642833B2 (ja) ヒト表皮細胞増殖因子の遺伝子
JPS63226288A (ja) 新規遺伝子、その発現プラスミドｄｎａ、及び形質転換微生物

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed